« Return to News | Awards & Advancement

CenterWatch Wins Gold for Best Healthcare Content

Thursday, November 20, 2008 10:00 AM

CenterWatch, a global source for clinical trials information, announced today that it is the three-time recipient of the Gold eHealthcare Leadership Award for Best Health/Healthcare Content in the Other Healthcare Sites category presented by Strategic Health Care Communications. The award, given at the 12th Annual Healthcare Internet Conference in Orlando, Fla., marks the fourth consecutive year CenterWatch has been honored winning platinum in 2005.

With more than 1,100 entrants competing in 17 classifications this year, the eHealthcare Leadership Awards program recognizes the best web sites in the healthcare industry and the Internet’s important role in helping organizations achieve their business goals.

“CenterWatch’s mission is to be the leading source of news, directories, proprietary market research, and analysis for both professionals and patients and this award speaks directly to our continued dedication to realize that goal,” said Chris Pooley, senior vice president and general manager of CenterWatch. “We are very proud to be recognized for our efforts once again.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.